glp-1 long-term risks Success of GLP-1s Hinges on More Than Just a Prescription Putting Medical Costs on a
Description
doi:10.1016/j.molmet.2018.12.001 36
Author Affiliations: Henry Ford Health, Center for Healthcare Improvement, Detroit, Michigan (Breitzig)
The Glucagon-Like Peptide 1 Analogue Exendin-4 Attenuates the Nicotine-Induced Locomotor Stimulation, Accumbal Dopamine Release, Conditioned Place Preference as Well as the Expression of Locomotor Sensitization in Mice
While many patients acclimate within weeks, others continue to struggle for months
P = 0.54
Yoshida Y, Joshi P, Barri S, Wang J, Corder AL, OConnell SS, et al
